ClinConnect ClinConnect Logo
Search / Trial NCT05694273

Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Jan 12, 2023

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Catheter Ablation Arrhythmia Major Adverse Cardiovascular And Cerebrovascular Events (Macce)

ClinConnect Summary

This clinical trial is looking at how often serious brain-related problems, like strokes, happen in patients who have a procedure called catheter ablation to treat heart rhythm issues, known as arrhythmias. The researchers want to understand the details of these events and how they affect patients shortly after the procedure. The main goal is to improve the care and quality of life for patients who undergo this treatment by reducing the risk of these complications.

To participate in this study, patients need to be between 18 and 80 years old and scheduled to have catheter ablation for arrhythmias. However, if someone has had a stroke or similar brain issue before the procedure, they cannot join. The trial is currently not recruiting participants, but it aims to gather important information that could help doctors manage the health of patients who have this heart treatment in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1.Patients who undergo catheter ablation for arrhythmias.
  • Exclusion Criteria:
  • 1. Patients were diagnosed of acute cerebrovascular disease prior to radiofrequency catheter ablation;
  • 2. Patients \< 18 years or \> 80 years;
  • 3. Patients with uncomplete clinical data.

About First Affiliated Hospital Xi'an Jiaotong University

The First Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution renowned for its commitment to advancing healthcare through clinical research and innovative treatment approaches. As a prominent academic hospital in China, it integrates clinical practice, education, and research, fostering a collaborative environment that enables the development of cutting-edge therapies and medical technologies. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital plays a pivotal role in conducting high-quality clinical trials that aim to improve patient outcomes and contribute to the global medical community.

Locations

Xi'an, Shaanxi, China

Patients applied

0 patients applied

Trial Officials

Guoliang Li

Principal Investigator

First Affiliated Hospital Xi'an Jiaotong University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials